W

Published on 09/04/2015 by admin

Filed under Surgery

Last modified 09/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 918 times

W

Wakefulness,  see Awareness

Wake-up test.  Intraoperative awakening to allow assessment of spinal cord function during spinal surgery. Has also been used to assess cerebral function during basilar artery clipping.

Warfarin sodium.  Oral anticoagulant drug, first synthesised in 1944. Rapidly absorbed by mouth and almost totally protein-bound. Competes with vitamin K in the synthesis of coagulation factors II, VII, IX and X in the liver; therefore requires 1–2 days for its effect to develop. Also inhibits protein C and S. Metabolised in the liver and excreted in urine and faeces. Half-life is about 30 h. Dosage is adjusted according to results of coagulation studies: the International Normalised Ratio (INR) is maintained at about 2–3 for prophylaxis and treatment of DVT, PE, transient ischaemic attacks and in patients with atrial fibrillation at high risk of embolisation; 3–4.5 for recurrent DVT/PE, cardiac and arterial prostheses. The usual maintenance dose is 3–9 mg/day. The INR is usually checked daily or on alternate days initially, but thereafter up to every 2 months, depending on the response.

Drugs causing hepatic enzyme induction (e.g. rifampicin, phenytoin) reduce its effect. If the second drug is withdrawn without reducing the dose of warfarin, haemorrhage may occur. Effects may be enhanced by drugs that displace it from protein-binding sites, e.g. sulphonamides, NSAIDs. Emergency treatment of haemorrhage due to excessive warfarin effect involves use of vitamin K injection (up to 5 mg iv) and the administration of factors II, VII, IX and X (prothrombin complex concentrate, or fresh frozen plasma).

Teratogenic; thus avoided in the first trimester of pregnancy, although there is evidence it may be more effective than heparin at preventing valve thrombosis and thus safer for pregnant women with prosthetic heart valves. Warfarin crosses the placenta, risking placental or fetal haemorrhage if given in the third trimester.

Patients taking warfarin who present for surgery may pose problems with perioperative coagulation. Suggested guidelines:

ent heart valves: maintain warfarin therapy for short (under 30 min) surgery, with fresh frozen plasma available. Otherwise, stop warfarin 3 days preoperatively, and start heparin infusion 24 h later (about 15 000 units/12 h), maintaining activated partial thromboplastin time (APTT) at 2–3 times normal. Stop heparin 6 h preoperatively, and check INR and APTT 1 h preoperatively. Surgery may be delayed, or plasma administered, if INR exceeds 1.5. Restart warfarin as soon as possible postoperatively, or heparin if nil by mouth for over 48 h. Extra precautions have been suggested for prosthetic mitral valves, since the risk of emboli is greater than for other valves: aspirin 75 mg or dipyridamole 300 mg/day is started when warfarin is stopped. Heparin is restarted 6–12 h postoperatively until able to take warfarin. Increasingly, low-mw heparin is being used to ‘bridge’ coagulation perioperatively instead of unfractionated heparin.

ent other conditions: stop warfarin for 48–72 h before surgery. The INR should be less than 1.5. Heparin may be given perioperatively sc to reduce thromboembolism until warfarin is restarted, or iv infusion used postoperatively in high-risk cases, e.g. recurrent PE.

ent emergency surgery: give vitamin K, and wait for synthesis of new clotting factors (about 6–12 h); this may interfere with subsequent anticoagulation for weeks afterwards. Alternatively, fresh frozen plasma or prothrombin complex concentrate may be given. The INR is monitored throughout.

[Wisconsin Alumni Research Foundation, where warfarin was developed]

Warren, John C (1778–1856).  Professor of Surgery and Anatomy at Harvard Medical School. It was at Warren’s invitation that Wells gave his demonstration of N2O anaesthesia, which ended in failure. Later, at Morton’s first public demonstration of diethyl ether, Warren performed the surgery.

Cooper DKC (2012). Br Med J; 345: 42–3

Water balance,  see Fluid balance

Water intoxication,  see Hyponatraemia

Waterhouse–Friderichsen syndrome,  see Adrenocortical insufficiency

Waters, Ralph Milton (1883–1979).  US anaesthetist; became Assistant Professor of Surgery in charge of anaesthetics at University of Wisconsin, leading to his appointment as the first university Professor of Anaesthesia in the USA (1933). Was the first to establish a resident training programme in anaesthesia and the first to use cyclopropane clinically (1930). Re-examined chloroform toxicity, advocated the use of inflatable cuffs on tracheal tubes, and was involved in many aspects of anaesthesia, including the use of thiopental and endobronchial intubation. Designed his ‘to-and-fro’ cannister for CO2 absorption in anaesthetic breathing systems, and the Waters airway, a metal oropharyngeal airway with a side-arm for attachment to a gas supply.

Waterton, Charles (1783–1865).  Squire of Walton Hall, Yorkshire; made his first voyage to South America in 1812. Described the preparation of curare and the blowpipes, darts, bows and arrows used by the Indians of the Amazon and Orinoco basins. Experimented with the drug on his return to England, and maintained life in a paralysed donkey by employing IPPV. Published details of his work and travels in Wanderings in South America (1825).

Watt.  Unit of power. One watt (W) = 1 joule per second (J/s).

[James Watt (1736–1819), Scottish engineer]

Waveforms.  Repetitive patterns plotted against time produce waveforms that may be complex (e.g. ECG) or simple, as in the sine wave. All complex waveforms may be mathematically deconstructed into component sine waves (Fourier analysis). For any sine wave, there is oscillation about a mean value, the maximal displacement from which is the amplitude. The number of complete oscillations per second is the frequency, and the distance between successive points at the same stage of the cycle is the wavelength. Waveform monitoring is very common in anaesthesia and intensive care, e.g. cardiovascular (ECG, intravascular pressures, plethysmography), respiratory (rate, depth, pattern), ventilatory (gas flow, pressure), neurological (intracranial pressure, EEG, nerve conduction studies).